Sysmex America, Inc., a diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, has announced that Ralph Taylor, the company’s CEO, will retire effective September 30, 2021. Ralph joined the company in 2007 as vice president of marketing and expanded his role to encompass Latin America and business development. In 2018, he became Sysmex America’s CEO, leading the region to strong sales and market performance, according to the company.

­Chief Operating Officer Andy Hay will serve as the company’s new CEO upon Taylor’s retirement. Andy began his career with the company 32 years ago when he joined the United Kingdom distributor of Sysmex hematology products and was a founding member of Sysmex United Kingdom. For the last 21 years, he has successfully led key areas of commercial operations including sales, marketing, R&D, training and operations for Sysmex America. During this time, he led the launch of multiple new products, introduced virtual instructor-led training with the opening of the Center for Learning and oversaw the development of several informatic solutions. Since 2018, he has served as Chief Operating Officer of Sysmex America and CEO of Sysmex Canada.

“Andy has consistently delivered results by aligning innovative technology with customer care, while maintaining clinical excellence in the healthcare community,” says Iwane Matsui, chairperson, Sysmex America. “Andy’s passion for excellence will drive even further growth in the Americas.”“I’m honored and excited to have the opportunity to work with our talented leadership team and employees around the world to advance [the company’s] growth strategy,” said Andy Hay. “It’s been my privilege to work with and learn from Ralph Taylor and [the company’s] prior CEOs.”

To learn more, visit Sysmex America.

Featured Image: Andy Hay. Photo: Sysmex America